The use of chitosan as a flocculant in mammalian cell culture dramatically improves clarification throughput without adversely impacting monoclonal antibody recovery

被引:52
作者
Riske, Frank [1 ]
Schroeder, James [1 ]
Belliveau, Julie [1 ]
Kang, Xuezhen [1 ]
Kutzko, Joseph [1 ]
Menon, Manoj K. [1 ]
机构
[1] Genzyme Corp, Framingham, MA 01701 USA
关键词
chitosan; clarification aid; cell culture harvest; monoclonal antibody; centrifugation; depth filtration;
D O I
10.1016/j.jbiotec.2006.12.023
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Hocculants have been employed for many years as aides in the clarification of wastewater, chemicals and food. Flocculants aggregate and agglutinate fine particles resulting in their settling from the liquid phase and a reduction in solution turbidity. These materials have not been widely used in the clarification of mammalian cell culture harvest. In this paper we examined chitosan as a flocculent of cells and cell particulates in NSO culture harvest and the subsequent further clarification of this material by continuous flow centrifugation followed by depth and absolute filtration. Chitosan is an ideal flocculant for biotechnology applications as it is produced from non-mammalian sources (typically arthropod shells) and is also available in a highly purified form that is low in heavy metals, volatile organics and microbial materials. Chitosan is a polymer of deacetylated chitin. The deacetylation imparts limited solubility on insoluble chitin and the amino groups on the polymer result in a polycationic material at acidic and neutral pH that can interact with polyanions, such as DNA and cell culture debris (typically negatively charged). Likely the interaction of chitosan with cell culture particulate forms a germinal center for further interaction and agglomeration of particulates thereby reducing the solubility of these materials resulting in their settling out into the solid phase. Chitosan improved the clarification throughput six to seven folds without a deleterious effect on monoclonal antibody recovery or purity. The procedure for utilizing chitosan is facile, easily implemented, and highly effective in improving material clarity and increasing material throughput. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:813 / 823
页数:11
相关论文
共 33 条
[1]  
ADACHI T, 1990, Patent No. 04040234
[2]   SELECTIVE FLOCCULATION WITH CHITOSAN IN ESCHERICHIA-COLI DISINTEGRATES - EFFECTS OF IONIC-STRENGTH AND MULTIVALENT METAL-IONS [J].
AGERKVIST, I ;
ERIKSSON, LB .
JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, 1993, 14 (03) :269-293
[3]  
GENTA I, 1995, STP PHARMA SCI, V5, P202
[4]  
GUALTIERI P, 1998, ANN INST PASTEUR MIC, V139, P717
[5]  
HASHIMOTO M, 1987, Patent No. 240348
[6]  
HUGHES J, 1990, Biotechnology Techniques, V4, P55, DOI 10.1007/BF00156611
[7]  
HUGHES J, 2004, Patent No. 200405121
[8]   Shear stress analysis of mammalian cell suspensions for prediction of industrial centrifugation and its verification [J].
Hutchinson, N. ;
Bingham, N. ;
Murrell, N. ;
Farid, S. ;
Hoare, M. .
BIOTECHNOLOGY AND BIOENGINEERING, 2006, 95 (03) :483-491
[9]  
ITO K, 2000, Patent No. 2001005995
[10]   Polyion complex micelles composed of all-trans retinoic acid and poly (ethylene glycol)-grafted-citosan [J].
Jeong, Young-Il ;
Kim, Sang-Hyo ;
Jung, Tae-Young ;
Kim, In-Young ;
Kang, Sam-Suk ;
Jin, Yong-Hao ;
Ryu, Hyang-Hwa ;
Sun, Heung-Suk ;
Jin, Shuguang ;
Kim, Kyung-Keun ;
Ahn, Kyu-Youn ;
Jung, Shin .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (11) :2348-2360